150 related articles for article (PubMed ID: 29755611)
1. Morphological Biomarker Differentiating MCI Converters from Nonconverters: Longitudinal Evidence Based on Hemispheric Asymmetry.
Long X; Jiang C; Zhang L
Behav Neurol; 2018; 2018():3954101. PubMed ID: 29755611
[TBL] [Abstract][Full Text] [Related]
2. Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters.
Ruiz de Miras J; Costumero V; Belloch V; Escudero J; Ávila C; Sepulcre J
Hum Brain Mapp; 2017 Dec; 38(12):5905-5918. PubMed ID: 28856799
[TBL] [Abstract][Full Text] [Related]
3. Distinct laterality alterations distinguish mild cognitive impairment and Alzheimer's disease from healthy aging: statistical parametric mapping with high resolution MRI.
Long X; Zhang L; Liao W; Jiang C; Qiu B;
Hum Brain Mapp; 2013 Dec; 34(12):3400-10. PubMed ID: 22927141
[TBL] [Abstract][Full Text] [Related]
4. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
[TBL] [Abstract][Full Text] [Related]
5. Quantitative MRI Brain Studies in Mild Cognitive Impairment and Alzheimer's Disease: A Methodological Review.
Leandrou S; Petroudi S; Kyriacou PA; Reyes-Aldasoro CC; Pattichis CS
IEEE Rev Biomed Eng; 2018; 11():97-111. PubMed ID: 29994606
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
[TBL] [Abstract][Full Text] [Related]
7. Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.
Zhao L; Luo Y; Lew D; Liu W; Au L; Mok V; Shi L;
Aging (Albany NY); 2019 Aug; 11(16):6217-6236. PubMed ID: 31467257
[TBL] [Abstract][Full Text] [Related]
8. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
[TBL] [Abstract][Full Text] [Related]
9. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
Beheshti I; Demirel H; Matsuda H;
Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
[TBL] [Abstract][Full Text] [Related]
10. Estimating individual trajectories of structural and cognitive decline in mild cognitive impairment for early prediction of progression to dementia of the Alzheimer's type.
Rajagopal SK; Beltz AM; Hampstead BM; Polk TA
Sci Rep; 2024 Jun; 14(1):12906. PubMed ID: 38839800
[TBL] [Abstract][Full Text] [Related]
11. How early can we predict Alzheimer's disease using computational anatomy?
Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
[TBL] [Abstract][Full Text] [Related]
12. Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
Gertje EC; Pluta J; Das S; Mancuso L; Kliot D; Yushkevich P; Wolk D
J Alzheimers Dis; 2016 Oct; 54(3):1027-1037. PubMed ID: 27567809
[TBL] [Abstract][Full Text] [Related]
13. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
[TBL] [Abstract][Full Text] [Related]
14. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.
Waragai M; Okamura N; Furukawa K; Tashiro M; Furumoto S; Funaki Y; Kato M; Iwata R; Yanai K; Kudo Y; Arai H
J Neurol Sci; 2009 Oct; 285(1-2):100-8. PubMed ID: 19552926
[TBL] [Abstract][Full Text] [Related]
15. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
16. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
[TBL] [Abstract][Full Text] [Related]
17. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
[TBL] [Abstract][Full Text] [Related]
19. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
[TBL] [Abstract][Full Text] [Related]
20. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment.
Bozzali M; Filippi M; Magnani G; Cercignani M; Franceschi M; Schiatti E; Castiglioni S; Mossini R; Falautano M; Scotti G; Comi G; Falini A
Neurology; 2006 Aug; 67(3):453-60. PubMed ID: 16894107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
